To hear about similar clinical trials, please enter your email below
Trial Title:
Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer
NCT ID:
NCT01052818
Condition:
Circulating Tumor Cells
Conditions: Official terms:
Neoplastic Cells, Circulating
Conditions: Keywords:
Non small-cell lung cancer
Circulating tumor cells
Carcinoembryonic antigen
Cytokeratin
Study type:
Observational
Overall status:
Unknown status
Study design:
Time perspective:
Prospective
Summary:
The purpose of the study is to evaluate the association between the number of circulating
tumor cells and response to treatment in non small-cell lung cancer patients
Detailed description:
In spite of technological advantages in diagnosis and treatment, lung cancer remains one
of the most deadly malignant neoplasias. Moreover, there are no markers for monitoring
response to treatment. The objective of the study is to associate the number of
circulating tumor cells (CTC) before and after treatment and correlate it with tumor
response rate, progression-free survival and overall survival.
Criteria for eligibility:
Study pop:
Advanced non small-cell lung cancer
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Histopathologic diagnosis of non small-cell lung cancer
- Clinical stage IV
- ECOG functional status 0 or 1
- No renal function alteration (GFR >50%)
- No hepatic function alteration (ALT and AST less than 2 times its normal value)
- Leucocytes more than 2,000/mcl
- Hemoglobin more than 10mg/dL
- Platelets more than 100,000/mcl
Exclusion Criteria:
Non-advanced disease
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
National Institute of Cancerologia
Address:
City:
Mexico City
Zip:
14080
Country:
Mexico
Status:
Recruiting
Contact:
Last name:
Oscar Arrieta, MD
Phone:
(0155)56280400
Phone ext:
832
Email:
ogar@servidor.unam.mx
Investigator:
Last name:
Oscar Arrieta, MD
Email:
Principal Investigator
Start date:
July 2007
Lead sponsor:
Agency:
National Institute of Cancerología
Agency class:
Other
Source:
National Institute of Cancerología
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT01052818
